Rheumatoid patients are not the sooner the biological agent the better, because the patient’s condition often has individualized differences, the physician needs to be based on the condition of the comprehensive judgment of which treatment plan is appropriate, the treatment process also needs to be adjusted according to the changes in the condition of the treatment. Biological agents are a new type of drugs for the treatment of rheumatic diseases, including adalimumab, tolizumab, abatacept and so on. After finding out the rheumatoid disease, you need to analyze whether you can take the biologics according to your own condition, and the doctor will make the best treatment plan according to the patient’s condition, not every patient can take the biologics, so there is no such thing as the earlier you take the biologics, the better it will be. Some patients with rheumatoid rheumatoid disease do not get good results from traditional anti-rheumatic treatment, which may cause related complications and even lead to joint deformity and loss of function. At this time, it is necessary to take biologics at an early stage to control synovial joint inflammation, reduce related diseases and prevent joint damage. Specific medication should be strictly in accordance with the doctor’s instructions, to avoid unauthorized use of adverse consequences.